Medical Condition

covid 19

Total Trials

19

Recruiting Now

19

Trial Phases

Phase 2, Phase 4

COVID-19 trials proliferated rapidly during the pandemic and now encompass antiviral treatments, long COVID management, and ongoing vaccine refinements for new variants. The platform trial model — where multiple interventions share a single control arm — was pioneered at scale for COVID-19 (RECOVERY, ACTIV-3, SOLIDARITY) and has since been adopted across other disease areas.

Active trials address long COVID (fatigue, cognitive impairment, autonomic dysfunction), antiviral combinations for high-risk outpatients, mucosal vaccines for variant-resistant immunity, and mechanistic studies into post-COVID organ damage. Paxlovid rebound, nirmatrelvir resistance, and immunocompromised host management are current investigation areas.

Frequently Asked Questions — covid 19 Clinical Trials

How many clinical trials are currently recruiting for covid 19?

ClinicalMetric currently tracks 19 actively recruiting clinical trials for covid 19, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 19. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for covid 19?

covid 19 research spans Phase 2 (3 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a covid 19 clinical trial?

Eligibility criteria for covid 19 trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 4

Top Sponsors

University of Chicago 2 trials

Euresist Network GEIE 2 trials

Centre Hospitalier Régional d'Orléans 1 trial

Columbia University 1 trial

IRCCS Burlo Garofolo 1 trial

covid 19

Frequently Asked Questions — covid 19 Clinical Trials

Recruiting Clinical Trials

Dysbiosis & Long COVID

Neutralizing Power of Serum Antibodies - 2

CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2

Empowerment and Burnout of Midwives at the End of Health Emergency From COVID-19

Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

The Role of Obesity in Severe COVID-19 Pathophysiology

Post COVID-19 Condition

Self-Management Interventions for Long COVID-19

Methodist Health System COVID-19 Patient Registry

Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project

Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India

COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

Immune Modulation by Exosomes in COVID-19

Community-Based Health Education Programs for the Early Detection of, and Vaccination Against, COVID-19 and the Adoption of Self-Protective Measures of Hong Kong Residents

A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection

Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases